HLB Genex, Inc. (KOSDAQ:187420)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,886.00
+10.00 (0.53%)
At close: Aug 24, 2026

HLB Genex Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
45,67043,37035,43027,00827,80225,874
Other Revenue
-0-----
45,67043,37035,43027,00827,80225,874
Revenue Growth
14.42%22.41%31.18%-2.85%7.45%37.85%
Cost of Revenue
29,33828,33221,12919,67717,58616,043
Gross Profit
16,33215,03814,3017,33110,2159,831
Selling, General & Admin
8,1337,1684,8694,0374,1302,919
Research & Development
6,3925,90310,27111,60811,68110,413
Amortization of Goodwill & Intangibles
37.9338.3444.5244.8144.542.49
Other Operating Expenses
---643.170.8468.78
Operating Expenses
15,28413,76316,14716,79516,44013,665
Operating Income
1,0481,276-1,846-9,464-6,224-3,834
Interest Expense
-11,667-10,996-4,257-5,506-6,328-3,963
Interest & Investment Income
1,1271,335521.641,0901,009431.41
Earnings From Equity Investments
-828.88-214.25----
Currency Exchange Gain (Loss)
564.1392.89383.9292.88220.13142.47
Other Non Operating Income (Expenses)
16,64529,502-12,7576,0911,215-6,451
EBT Excluding Unusual Items
6,88921,296-17,955-7,696-10,108-13,674
Gain (Loss) on Sale of Investments
3,5292,475--2,047-1,572-619.8
Gain (Loss) on Sale of Assets
192117.84-96.38-211.99-7.43-108.57
Asset Writedown
--0.54-142.61-1,833--0.02
Other Unusual Items
-40.9716.121,29611,001351.77-
Pretax Income
10,56923,905-16,898-786.51-11,336-14,402
Income Tax Expense
844.851,0071,035-64.762,037-5,876
Earnings From Continuing Operations
9,72422,898-17,933-721.75-13,373-8,526
Minority Interest in Earnings
-460.24-306.39-895.34-2,228405.121,710
Net Income
9,26422,591-18,828-2,950-12,968-6,817
Net Income to Common
9,26422,591-18,828-2,950-12,968-6,817
Net Income Growth
------
Shares Outstanding (Basic)
302924232322
Shares Outstanding (Diluted)
444824232322
Shares Change
62.65%105.88%4.10%0.44%0.30%2.01%
EPS (Basic)
310.96775.35-800.00-130.50-576.16-303.76
EPS (Diluted)
310.96606.00-800.00-130.50-576.16-304.00
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3,5432,6822,221-6,028-8,732-11,102
Free Cash Flow Per Share
81.2455.3494.39-266.63-387.97-494.72
Gross Margin
35.76%34.67%40.36%27.14%36.74%38.00%
Operating Margin
2.29%2.94%-5.21%-35.04%-22.39%-14.82%
Profit Margin
20.28%52.09%-53.14%-10.92%-46.64%-26.35%
Free Cash Flow Margin
7.76%6.18%6.27%-22.32%-31.41%-42.91%
EBITDA
5,3925,7462,640-4,824-1,782-95.46
EBITDA Margin
11.81%13.25%7.45%-17.86%-6.41%-0.37%
D&A For EBITDA
4,3444,4714,4874,6404,4423,739
EBIT
1,0481,276-1,846-9,464-6,224-3,834
EBIT Margin
2.29%2.94%-5.21%-35.04%-22.39%-14.82%
Effective Tax Rate
7.99%4.21%----
Advertising Expenses
-180.66146.4959.8286.9726.09